1. Home
  2. DIT vs SER Comparison

DIT vs SER Comparison

Compare DIT & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMCON Distributing Company

DIT

AMCON Distributing Company

HOLD

Current Price

$60.00

Market Cap

64.4M

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$1.73

Market Cap

56.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIT
SER
Founded
1981
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.4M
56.4M
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
DIT
SER
Price
$60.00
$1.73
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $9.50
AVG Volume (30 Days)
1.5K
★ 28.7K
Earning Date
08-05-2026
11-12-2026
Dividend Yield
★ 0.79%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.40
N/A
Revenue
★ $1,392,388,157.00
$130,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$42.86
★ N/A
Revenue Growth
5.30
★ 132.14
52 Week Low
$59.15
$1.22
52 Week High
$122.00
$5.29

Technical Indicators

Market Signals
Indicator
DIT
SER
Relative Strength Index (RSI) 38.65 35.23
Support Level $59.15 $1.73
Resistance Level $74.55 $1.86
Average True Range (ATR) 1.89 0.11
MACD -0.37 -0.02
Stochastic Oscillator 0.00 15.38

Price Performance

Historical Comparison
DIT
SER

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: